Sotera Health (SHC) Expected to Post Quarterly Earnings February 27

Sotera Health (NASDAQ:SHC) is set to announce its quarterly earnings on February 27, with analysts predicting earnings of $0.21 per share and revenue of approximately $291 million, reflecting a decline from the previous year. Despite the expected downturn, the company has received a 'Moderate Buy' rating from six research firms, with an average target price of $16.08. Recent analyst reports indicate varied perspectives, with Citigroup raising its price target to $20 and Barclays reducing it to $17. In contrast, the consensus estimate for Sotera’s earnings has not changed over the past month, suggesting analysts are holding steady on their projections. Meanwhile, HCA Healthcare (NYSE:HCA) has also been rated as a 'Moderate Buy' by brokerages, with a collective price target of $385.67, amid mixed ratings from various analysts. Both companies reflect the cautious optimism and volatility in the healthcare sector as they approach their respective earnings announcements.